Status:
COMPLETED
Atrial Fibrillation: Risk and Benefits of Anti-coagulation in the Elderly
Lead Sponsor:
Karolinska Institutet
Conditions:
Anticoagulants Causing Adverse Effects in Therapeutic Use
Atrial Fibrillation
Eligibility:
All Genders
75+ years
Brief Summary
This study was designed to assess the effectiveness of oral anticoagulants in elderly patients (\>=75 years) with atrial fibrillation. All patients discharged from one large hospital in Stockholm, Dan...
Detailed Description
The investigators established a prospective cohort of 2943 of elderly (\>=75 years old) discharged with atrial fibrillation as main diagnosis from November 1st 2010 to December 31st 2017 from a large ...
Eligibility Criteria
Inclusion
- • All consecutive patients discharged with atrial fibrillation as main diagnosis from Danderyds Hospital from November 1st 2011 to December 31 2017 aged 75 years or more.
Exclusion
- Patients who have not given their consensus to the use of medical journals for register based research.
- Patients who were discharged from the hospital with atrial fibrillation as main diagnosis but were admitted to the hospital for medical reasons unrelated to atrial fibrillation (as an example change of pacemakers batteries).
- Patients whose medical records are not consistent with the main diagnosis (as an example wrong ICD code).
Key Trial Info
Start Date :
November 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2018
Estimated Enrollment :
2943 Patients enrolled
Trial Details
Trial ID
NCT03828162
Start Date
November 1 2010
End Date
December 31 2018
Last Update
February 4 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.